EUVIMEDEUVIMED entdecken
Multizentrische Studie

Prognostic Value of Microvascular Function in Takotsubo Syndrome

Rob Eerdekens, Mohamed El Farissi, Giovanni Luigi De Maria, Aviel Shetrit, Robert Sykes, Christina Ekenbäck, Jonas Persson, Jonas Spaak, Liam S Couch, Fernando Alfonso, Fernando Rivero, Nieves Gonzalo und 14 weitere

JACC: Cardiovascular Interventions · 2025-07 · 18 (13) · 1646-1656

DOI: 10.1016/j.jcin.2025.05.028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-07. Verfasst von Rob Eerdekens und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands. Hauptthemen laut MEDLINE: Microcirculation, Coronary Circulation, Takotsubo Cardiomyopathy, Cardiac Catheterization. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: British Heart Foundation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo syndrome (TTS). However, the prognostic value of microvascular function measured in the acute phase of TTS is unclear. OBJECTIVES: This study sought to assess the prognostic value of microvascular function measured invasively in the acute phase of TTS. METHODS: In a collaborative, pooled analysis of individual patient data from 9 prospective TTS cohorts, invasive assessment of coronary microvascular function was performed, including the index of microcirculatory resistance (IMR), coronary flow reserve, and microvascular resistance reserve. The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCE) defined as the composite of all-cause death, recurrence of TTS, stroke, transient ischemic attack, or myocardial infarction. RESULTS: A total of 166 patients with TTS were included, in whom 130 (78%) had the typical (apical) TTS variant and 36 (22%) had an atypical variant. During a median follow-up of 20.6 [4.3-60.0] months, all-cause mortality occurred in 17 patients (10.2%) and MACCE in 29 patients (17.5%). IMR, coronary flow reserve, and microvascular resistance reserve were associated with all-cause mortality. After adjustment for baseline differences, IMR was the only independent predictor of both all-cause mortality (aHR: 3.9; 95% CI: 1.39-10.88; P = 0.010; c-statistic 0.817; 95% CI: 0.711-0.923) and MACCE (aHR: 2.6; 95% CI: 1.17-5.67; P = 0.018; c-statistic 0.719; 95% CI: 0.612-0.826). CONCLUSIONS: In this pooled analysis of individual patient data from 9 prospective TTS cohorts, microvascular dysfunction measured in the acute phase was associated with all-cause mortality. In particular, an elevated microvascular resistance, as assessed by IMR, was the only independent predictor of both mortality and MACCE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrocirculationCoronary CirculationTakotsubo CardiomyopathyCardiac CatheterizationCoronary VesselsHumansFemaleMaleAgedRisk FactorsPredictive Value of TestsVascular ResistanceMiddle AgedTime FactorsProspective StudiesRisk AssessmentRecurrencePrognosis

Stichwörter der Autor:innen

IPDTakotsuboanalysismicrovascular functionpooled

Autor:innen und Institutionen

  • Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
  • Oxford Heart Centre, Oxford University Hospitals, NHS Trust, Oxford, United Kingdom.
  • Departments of Cardiology, Tel Aviv Sourasky Medical Center, affiliated with Tel Aviv School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • West of Scotland Regional Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom; British Heart Foundation, Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Heal…
  • Karolinska Institute, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden.
  • Department of Cardiology, Hospital Universitario de La Princesa, Universidad Autonoma de Madrid, CIBER-CV, IIS-IP, Madrid, Spain.

Förderung

  • British Heart Foundation
  • Medical Research Council

Zitieren

APA

Eerdekens, R., El Farissi, M., De Maria, G. L., Shetrit, A., Sykes, R., Ekenbäck, C., Persson, J., Spaak, J., Couch, L. S., Alfonso, F., Rivero, F., Gonzalo, N., Escaned, J., Núñez Gil, I. J., Cruz, O. V., Shamir, R. A., Freund, O., Vanderheyden, M., Belmonte, M., …, & Zimmermann, F. M. (2025). Prognostic Value of Microvascular Function in Takotsubo Syndrome. JACC: Cardiovascular Interventions, 18(13), 1646-1656. https://doi.org/10.1016/j.jcin.2025.05.028

Vancouver

Eerdekens R, El Farissi M, De Maria GL, Shetrit A, Sykes R, Ekenbäck C, et al. Prognostic Value of Microvascular Function in Takotsubo Syndrome. JACC: Cardiovascular Interventions. 2025;18(13):1646-1656. doi:10.1016/j.jcin.2025.05.028

BibTeX
@article{Eerdekens2025,
  author = {Eerdekens, Rob and El Farissi, Mohamed and De Maria, Giovanni Luigi and Shetrit, Aviel and Sykes, Robert and Ekenbäck, Christina and Persson, Jonas and Spaak, Jonas and Couch, Liam S and Alfonso, Fernando and Rivero, Fernando and Gonzalo, Nieves and Escaned, Javier and Núñez Gil, Iván J and Cruz, Oscar Vedia and Shamir, Reut Amar and Freund, Ophir and Vanderheyden, Marc and Belmonte, Marta and Barbato, Emanuele and Tonino, Pim A L and Banning, Adrian and Solberg, Ole Geir and Berry, Colin and Fearon, William F and Zimmermann, Frederik M},
  title = {Prognostic Value of Microvascular Function in Takotsubo Syndrome},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {13},
  pages = {1646--1656},
  doi = {10.1016/j.jcin.2025.05.028}
}
Kostenlos starten →